Berezhnoy A - Search Results

1

Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.

Schrand B, Berezhnoy A, Brenneman R, Williams A, Levay A, Kong LY, Rao G, Zhou S, Heimberger AB, Gilboa E. Schrand B, et al. Among authors: berezhnoy a. Cancer Immunol Res. 2014 Sep;2(9):867-77. doi: 10.1158/2326-6066.CIR-14-0007. Epub 2014 Jun 17. Cancer Immunol Res. 2014. PMID: 24938283 Free PMC article.

2

Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery.

Gilboa E, Berezhnoy A, Schrand B. Gilboa E, et al. Among authors: berezhnoy a. Cancer Immunol Res. 2015 Nov;3(11):1195-200. doi: 10.1158/2326-6066.CIR-15-0194. Cancer Immunol Res. 2015. PMID: 26541880 Review.

3

Aptamer-Targeted Attenuation of IL-2 Signaling in CD8⁺ T Cells Enhances Antitumor Immunity.

Rajagopalan A, Berezhnoy A, Schrand B, Puplampu-Dove Y, Gilboa E. Rajagopalan A, et al. Among authors: berezhnoy a. Mol Ther. 2017 Jan 4;25(1):54-61. doi: 10.1016/j.ymthe.2016.10.021. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129128 Free PMC article.

4

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition.

Berezhnoy A, Brenneman R, Bajgelman M, Seales D, Gilboa E. Berezhnoy A, et al. Mol Ther Nucleic Acids. 2012 Oct 16;1(10):e51. doi: 10.1038/mtna.2012.41. Mol Ther Nucleic Acids. 2012. PMID: 23344651 Free PMC article.

5

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment.

Levay A, Brenneman R, Hoinka J, Sant D, Cardone M, Trinchieri G, Przytycka TM, Berezhnoy A. Levay A, et al. Among authors: berezhnoy a. Nucleic Acids Res. 2015 Jul 13;43(12):e82. doi: 10.1093/nar/gkv534. Epub 2015 May 24. Nucleic Acids Res. 2015. PMID: 26007661 Free PMC article.

6

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.

Garrido G, Schrand B, Rabasa A, Levay A, D'Eramo F, Berezhnoy A, Modi S, Gefen T, Marijt K, Doorduijn E, Dudeja V, van Hall T, Gilboa E. Garrido G, et al. Among authors: berezhnoy a. Nat Commun. 2019 Aug 21;10(1):3773. doi: 10.1038/s41467-019-11728-2. Nat Commun. 2019. PMID: 31434881 Free PMC article.

7

Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing.

Berezhnoy A, Stewart CA, Mcnamara JO 2nd, Thiel W, Giangrande P, Trinchieri G, Gilboa E. Berezhnoy A, et al. Mol Ther. 2012 Jun;20(6):1242-50. doi: 10.1038/mt.2012.18. Epub 2012 Mar 20. Mol Ther. 2012. PMID: 22434135 Free PMC article.

8

Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.

Berezhnoy A, Castro I, Levay A, Malek TR, Gilboa E. Berezhnoy A, et al. J Clin Invest. 2014 Jan;124(1):188-97. doi: 10.1172/JCI69856. J Clin Invest. 2014. PMID: 24292708 Free PMC article.

9

Aptamer-mediated transcriptional gene silencing of Fox p 3 inhibits regulatory T cells and potentiates antitumor response.

Manrique-Rincón AJ, Ruas LP, Fogagnolo CT, Brenneman RJ, Berezhnoy A, Castelucci B, Consonni SR, Gilboa E, Bajgelman MC. Manrique-Rincón AJ, et al. Among authors: berezhnoy a. Mol Ther Nucleic Acids. 2021 May 8;25:143-151. doi: 10.1016/j.omtn.2021.05.005. eCollection 2021 Sep 3. Mol Ther Nucleic Acids. 2021. PMID: 34457999 Free PMC article.

10

AptaCluster - A Method to Cluster HT-SELEX Aptamer Pools and Lessons from its Application.

Hoinka J, Berezhnoy A, Sauna ZE, Gilboa E, Przytycka TM. Hoinka J, et al. Among authors: berezhnoy a. Res Comput Mol Biol. 2014;8394:115-128. doi: 10.1007/978-3-319-05269-4_9. Res Comput Mol Biol. 2014. PMID: 25558474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters